🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To Evaluate the Safety, Tolerability and Pharmacokinetics on DA-302168S Tab...
Status
Completed
Location
Gulou Hospital Affiliated to Nanjing Medical University
Start Date
2024-04-18
Trial ID
NCT06534320
Treatments Being Tested
A PHASE 1, RANDOMIZED, PLACEBO CONTROLLED, MULTIPLE ASCENDING DOSE (MAD) ST...
Status
Completed
Location
Altasciences
Start Date
2023-01-06
Trial ID
NCT06025396
Treatments Being Tested
The goal of this clinical trial is to evaluate the safety, tolerability, an...
Status
Enrolling By Invitation
Location
The first hospital of Lanzhou University
Start Date
2024-07-05
Trial ID
NCT06782958
To evaluate the safety, tolerability and pharmacokinetics of single and mul...
Status
Not Yet Recruiting
Location
Huashan Hospital affiliated to Fudan University
Start Date
2026-07-30
Trial ID
NCT07719257
A Phase 1, Randomized, Double-blind, Placebo-controlled Study of Orally Adm...
Status
Completed
Location
Labcorp Cru
Start Date
2022-08-08
Trial ID
NCT05349097
Treatments Being Tested
This is a randomized, double-blind, and placebo-controlled phase I clinical...
Status
Completed
Location
The Second Hospital of Anhui Medical University
Start Date
2022-08-08
Trial ID
NCT05504746
Treatments Being Tested
A randomized, double-blind, placebo-controlled trial design was used to ass...
Status
Unknown
Location
The Affiliated Hospital of Qingdao University
Start Date
2022-06
Trial ID
NCT05409326
Treatments Being Tested
A Phase 1, Partially Blind, Placebo Controlled, Randomized, Combined Single...
Status
Completed
Location
Worldwide Clinical Trials
Start Date
2020-06-08
Trial ID
NCT04493671
Treatments Being Tested
A Phase I, single-center, randomized, double-blind, placebo-controlled stud...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT02819687
A randomized, double-blinded, partial-open, placebo/active-controlled, sing...
Status
Recruiting
Location
Seoul National University Hospital
Start Date
2026-03-23
Trial ID
NCT07433556
Treatments Being Tested